SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-23-018328
Filing Date
2023-11-09
Accepted
2023-11-08 17:44:20
Documents
14
Period of Report
2023-11-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K rsls-20231108x8k.htm   iXBRL 8-K 35091
2 EX-99.1 rsls-20231108xex99d1.htm EX-99.1 259645
3 GRAPHIC rsls-20231108xex99d1001.jpg GRAPHIC 3934
  Complete submission text file 0001558370-23-018328.txt   435202

Data Files

Seq Description Document Type Size
4 EX-101.SCH rsls-20231108.xsd EX-101.SCH 3108
5 EX-101.LAB rsls-20231108_lab.xml EX-101.LAB 15243
6 EX-101.PRE rsls-20231108_pre.xml EX-101.PRE 9784
8 EXTRACTED XBRL INSTANCE DOCUMENT rsls-20231108x8k_htm.xml XML 4671
Mailing Address 1001 CALLE AMANECER SAN CLEMENTE CA 92673
Business Address 1001 CALLE AMANECER SAN CLEMENTE CA 92673 949-429-6680
ReShape Lifesciences Inc. (Filer) CIK: 0001427570 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37897 | Film No.: 231389418
SIC: 3841 Surgical & Medical Instruments & Apparatus